Global Blood Therapeutics, Inc.

GBTNASDAQHealthcare

$68.49

+$0.01(+0.01%)

Market Cap$0

P/E Ratio—

52W High$73.02

52W Low$21.65

Avg Volume3.7M

Open$68.48

Beta0.46

Overview

Global Blood Therapeutics, Inc. (GBT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · GBT · as of Feb 23, 2022

Latest filing snapshot

457

+68+17.48%vs prior year

Global Blood Therapeutics, Inc. (GBT) employee data is sourced from the annual SEC 10-K filing. As of 2021, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2021-12-31·Full-time · Global

Total Employees

457

Change (1Y)

+68

Growth % (1Y)

+17.48%

Revenue / Employee

$426.1K

Net Income / Employee

$-663.2K

Market Cap

$0M

GBT Employee Count

2015 – 2021 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2022-02-23	2021-12-31	457	+68	+17.48%
2021-02-24	2020-12-31	389	+37	+10.51%
2020-02-26	2019-12-31	352	+181	+105.85%
2019-02-27	2018-12-31	171	+24	+16.33%
2018-02-27	2017-12-31	147	+52	+54.74%
2017-03-13	2016-12-31	95	+40	+72.73%
2016-03-29	2015-12-31	55	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

MRTX

Mirati Therapeutics, Inc.

Global Blood Therapeutics, Inc.YOU

Alpine Immune Sciences, Inc.

142$4.5B #6

MORF

Morphic Holding, Inc.

128$2.9B #7

CBAY

CymaBay Therapeutics, Inc.

101$3.7B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · GBT peer comparison

About GBT employees

GBT Employees · Headcount

Global Blood Therapeutics, Inc. (GBT) employee data is sourced from the annual SEC 10-K filing. As of 2021, Global Blood Therapeutics, Inc. had 457 full-time employees globally. Full-time employees only. Global consolidated headcount.

Global Blood Therapeutics, Inc. employs 457 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $426,147, reflecting the company's operational efficiency.

Global Blood Therapeutics, Inc.'s workforce increased by 68 (17.48%) in 2021 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Global Blood Therapeutics, Inc.'s revenue per employee of $426,147 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

GBT Employees · 5 questions

As of the latest SEC 10-K filing (2021), Global Blood Therapeutics, Inc. had 457 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Global Blood Therapeutics, Inc. employee counthow many employees does Global Blood Therapeutics, Inc. haveGBT total employees 2021

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2022-02-23